Back
ILA
Island Pharmaceuticals Limited
π¦πΊ ASX
π¦ LOGISTICS
π Overview
π Performance
π΅ Cost
π€ Advanced
π¨βπ©βπ§βπ¦ Community
π
+ 14.31%
Annual Growth
4 years average annual capital growth
π΅
$ 500
Minimum Order
Due to regulatory requirements
π
3
Pearlers Invested
Since January 2020
π Overview
Key information
π Fund Overview
Island Pharmaceuticals Ltd. is a drug research and repurposing company, focused on developing preventative or therapeutic drugs for viral infections. The company is headquartered in Melbourne, Victoria. The company went IPO on 2021-04-13. The firm is focused on areas of unmet need for antiviral therapeutics to address infectious diseases. Its lead asset is ISLA-101, a drug with a safety profile being repurposed for the prevention and treatment of dengue2 fever and other mosquito (or vector) borne diseases. ISLA-101 has been shown to have activity against all four strains of dengue virus as well as other flaviviruses such as Zika virus, West Nile virus, and Yellow Fever virus, as well as Chikungunya virus. While ISLA-101 is an oral formulation, the Company is also considering alternative formulations, including a long-acting oral formulation and intravenous formulations for severe dengue infections. The firm operates a single segment, being research and development activities principally in the geographic regions of Australia and the United States. Its subsidiary is Isla Pharmaceuticals Inc.
π Performance
Price History
+64.00%
1M
1Y
All Time
Graph
Table
Unsure how much or often to invest?
ποΈ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out βπ΅ Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out ββ±οΈ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out βπ΅ Costs
πΌ
N/A
Management Fee
Included in unit price, not charged by Pearler
πΈ
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πΈ Net fee calculatorπ€ Advanced information
Technical Info
π° Price*
$0.41
*Price may be up to 24 hours old
π©βπ©βπ¦ Community Insights
How our community is investing
π Pearlers invested in ILA
3
π Total Capital Earnings
$45K
π Average investment frequency
19 weeks
π΅ Average investment amount
$867
β° Last time a customer invested in ILA
132 days
ILA investor breakdown
π΅ Income of investors
More than 200k
150k - 200k
20%
100k - 150k
40%
50k - 100k
Less than 50k
40%
πΆ Age of investors
18 - 25
26 - 34
35 - 90
100%
π Legal gender of investors
Female
Male
100%
Pearlers who invest in ILA also invest in...
PharmAust Ltd. engages in the business of developing own drug discovery intellectual property for the treatment of different types of cancers, neurological diseases, and viral infections; and providing highly specialized medicinal and synthetic chemistry services on a contract basis to clients. The company is headquartered in South Melbourne, Victoria. The company went IPO on 2001-10-05. The Companyβs segments include Corporate and Research. The firm is focused on repurposing monepantel (MPL) for human neurodegenerative diseases. The firm's lead candidate, Monepantel (MPL), is a potent and safe inhibitor of the mTOR pathway, that plays a central role in cell growth and proliferation of cancer cells and in degenerating neurons. The firm is also developing MPL as a treatment for motor neuron disease (MND/ALS), a rare, incurable disease. The company is focused on starting Phase II/III clinical study of MPL. The company has also completed a Phase II oncology clinical study of MPL in humans and pilot studies in canine cancer. The company is also preparing a pivotal monepantel field trial in dogs with B-Cell Lymphoma to enable product registration in the United States.
π Performance (5Yr p.a)
15.38%
π Share price
$0.23 AUD
π¦ LOGISTICS
π HIGH PRICE GROWTH
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
π Performance (5Yr p.a)
17.60%
π Share price
$149.80 AUD
π GLOBAL
π€ TECHNOLOGY
β³οΈ DIVERSIFIED
π HIGH PRICE GROWTH
Fortescue Ltd. engages in the development of iron ore deposits. The company is headquartered in Perth, Western Australia. The firm's segments include Metals and Energy. Metals segment includes exploration, development, production, processing, sale and transportation of iron ore, and the exploration for other minerals. Its metals business comprises its iron ore operations in the Pilbara as well as a pipeline of exploration projects globally including in Gabon in Africa, Latin America and Australia. The firm's metals business includes Hedland operations, Chichester Hub, Western Hub, Iron Bridge, Green Metal Project, integrated operations, Belinga Project, Blacksmith Project and Pilbara Energy Connect (PEC) project. Energy segment undertakes activities in the global development of green electricity, green hydrogen, green ammonia projects, as well as green technology development and manufacturing. Its energy business includes Arizona Hydrogen project, Holmaneset project, Pecem project and Gladstone PEM50 Project.
π Performance (5Yr p.a)
2.71%
π Share price
$18.94 AUD
ποΈ SOCIALLY AWARE
βοΈ MINING
π° HIGH DIVIDEND
A200.AX was created on 2018-05-07 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The ETF currently has 8332.1m in AUM and 198 holdings. A200.AX aims to track the performance of an index (before fees and expenses) comprising 200 of the largest companies by market capitalisation listed on the ASX.
π Performance (5Yr p.a)
9.91%
π Share price
$147.30 AUD
πΈ FINANCIALS
π HIGH PRICE GROWTH
π¦πΊ AUSTRALIA
β³οΈ DIVERSIFIED
South32 Ltd. operates as a metal and mining company. The company is headquartered in Perth, Western Australia and currently employs 8,892 full-time employees. The company went IPO on 2015-05-18. Its segments include Worsley Alumina, Brazil Alumina, Brazil Aluminium, Hillside Aluminium, Mozal Aluminium, Sierra Gorda, Cannington, Hermosa, Cerro Matoso, Australia Manganese and South Africa Manganese. Worsley Alumina segment includes an integrated bauxite mine and an alumina refinery in Australia. Brazil Alumina segment consists of an integrated bauxite mine and an alumina refinery in Brazil. Brazil Aluminium segment is engaged in aluminum smelter in Brazil. Hillside Aluminium segment is focused on aluminum smelter in South Africa. Mozal Aluminium segment is engaged in aluminum smelter in Mozambique. Sierra Gorda segment is focused on copper mine in Chile. Cannington segment includes silver, lead and zinc mines in Australia. Hermosa segment includes base metals exploration and development project in the United States. Cerro Matoso segment includes an integrated laterite ferronickel mine and smelting complex in Colombia.
π Performance (5Yr p.a)
6.32%
π Share price
$2.75 AUD
βοΈ MINING
Want more shares? Try these...